eEML - Electronic Essential Medicines List

export

Export

Cisplatin

Essential medicine status

General description

Cisplatin is a platinum-based antineoplastic agent used to treat many types of cancer.

INN

Cisplatin

Medicine type

Chemical agent

EML status history

First added in 1984 (TRS 722) for Osteosarcoma of bone and articular cartilage of unspecified sites

Added in 1984 (TRS 722) for Malignant neoplasms of cervix uteri

Added in 1984 (TRS 722) for Germ cell tumour of testis

Added in 1984 (TRS 722) for Other specified malignant neoplasms of bronchus or lung

Added in 1984 (TRS 722) for Other specified malignant neoplasms of the ovary

Added in 1984 (TRS 722) for Malignant neoplasms of nasopharynx

Added in 1984 (TRS 722) for Squamous cell carcinoma of oropharynx

Added in 1984 (TRS 722) for Unspecified malignant neoplasms of ill-defined or unspecified sites

Removed in 2009 (TRS 958) for Unspecified malignant neoplasms of ill-defined or unspecified sites

Wikipedia

DrugBank

Recommendations

Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL

Indications

Unspecified malignant neoplasms of ill-defined or unspecified sites Other specified malignant neoplasms of the ovary Germ cell tumour of testis Osteosarcoma of bone and articular cartilage of unspecified sites Other specified malignant neoplasms of bronchus or lung Malignant neoplasms of nasopharynx Malignant neoplasms of cervix uteri Squamous cell carcinoma of oropharynx